KEY FEATURES
| Full Name | Factor Related Apoptosis Ligand |
|---|---|
| Synonym | FASLG;ALPS1B;APT1LG1;APTL;CD178;CD95L; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 15.63-1000pg/mL |
| Sensitivity | 9.38pg/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human FASL/TNFSF6 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human FASL/TNFSF6. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human FASL/TNFSF6 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human FASL/TNFSF6, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human FASL/TNFSF6. You can calculate the concentration of Human FASL/TNFSF6 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human FASL/TNFSF6 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (pg/mL) | 52.54 | 139.74 | 421.24 | 57.21 | 152.74 | 458.86 |
| Standard deviation | 2.94 | 6.68 | 18.53 | 3.14 | 7.91 | 17.12 |
| CV(%) | 5.59 | 4.78 | 4.4 | 5.49 | 5.18 | 3.73 |
RECOVERY
The recovery of Human FASL/TNFSF6 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 86-97 | 92 |
| EDTA plasma (n=8) | 92-103 | 97 |
| Cell culture media (n=8) | 92-104 | 98 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human FASL/TNFSF6 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with FAS ELISA Kits
| FAS ELISA Kit | publications with FAS and FAS |
| FADD ELISA Kit | publications with FAS and FADD |
| SRC ELISA Kit | publications with FAS and SRC |
| TNFRSF6B ELISA Kit | publications with FAS and TNFRSF6B |
| PTPN13 ELISA Kit | publications with FAS and PTPN13 |
| LCK ELISA Kit | publications with FAS and LCK |
| DAXX ELISA Kit | publications with FAS and DAXX |
| EGR2 ELISA Kit | publications with FAS and EGR2 |
| EGR3 ELISA Kit | publications with FAS and EGR3 |
| FYN ELISA Kit | publications with FAS and FYN |
Pathways associated with FAS ELISA Kit
| African Trypanosomiasis Pathway | African Trypanosomiasis Pathway |
| Allograft Rejection Pathway | Allograft Rejection Pathway |
| Apoptosis Pathway | Apoptosis Pathway |
| Apoptosis Modulation And Signaling Pathway | Apoptosis Modulation And Signaling Pathway |
| Autoimmune Thyroid Disease Pathway | Autoimmune Thyroid Disease Pathway |
Diseases associated with FAS ELISA Kit
| Neoplasms | publications with FAS and Neoplasms |
| Necrosis | publications with FAS and Necrosis |
| Inflammation | publications with FAS and Inflammation |
| Liver Diseases | publications with FAS and Liver Diseases |
| Nervous System Diseases | publications with FAS and Nervous System Diseases |
| Hepatitis | publications with FAS and Hepatitis |
| Drug Toxicity | publications with FAS and Drug Toxicity |
| Breast Neoplasms | publications with FAS and Breast Neoplasms |
| Neoplasms, Experimental | publications with FAS and Neoplasms, Experimental |
| Melanoma | publications with FAS and Melanoma |
Organs/Tissues associated with FAS ELISA Kit
| Blood | publications with FAS and Blood |
| Bone Marrow | publications with FAS and Bone Marrow |
| Intestine | publications with FAS and Intestine |
| Prostate | publications with FAS and Prostate |
| Spleen | publications with FAS and Spleen |
| Uterus | publications with FAS and Uterus |